Earnings Call · Q1 FY2023·2023-05-02

Q1 23EPS +24.24%·Rev n/aQ4 22EPS +9.62%·Rev n/aQ3 22EPS +27.14%·Rev n/aQ2 22EPS +14.61%·Rev n/a⚠ consensus missing

PFIZER INC PFE

Chris Stevo — Senior Vice President and Chief Investor Relations Officer

Dr. Albert Bourla — Chairman and Chief Executive Officer

Dave Denton — Chief Financial Officer

Dr. Mikael Dolsten — President, Worldwide Research and Development and Medical

−0.4%1d on move date+0.7% vs SPY3d−2.5%5d−1.4%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PFE calls or request research access.

More PFE calls Browse calls Request research access